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ABSTRACT Clinical reference textbooks lack data for pyrrolidonyl arylamidase (PYR)
activity in Staphylococcus delphini. This study evaluated PYR activities of 21 S. del-
phini strains by reference broth, rapid disc, and rapid slide methods. Species and
subgroup identifications were confirmed by nucleic acid-based methods and in-
cluded nine group A and 12 group B strains. Testing by rapid PYR methods with
products from four manufacturers was performed at two testing locations, and, with
the exception of one strain tested at one location using reagents from one manufac-
turer, each S. delphini strain tested positive for PYR activity. Therefore, PYR may be a
useful single-test adjunct for distinguishing Staphylococcus aureus from S. delphini
and other members of the Staphylococcus intermedius group.
KEYWORDS Staphylococcus delphini, Staphylococcus intermedius group, pyrrolidonyl
arylamidase
Pyrrolidonyl arylamidase (PYR), also known as pyrrolidonyl aminopeptidase, is abacterial enzyme that hydrolyzes L-pyroglutamic acid--naphthylamide to produce
-naphthylamine, which combines with N,N-dimethylaminocinnamaldehyde reagent to
form a red color (1). Rapid disc or slide tests for PYR activity are used to differentiate
Enterococcus species from Streptococcus species (1) but can also be used to presump-
tively differentiate Staphylococcus aureus from phenotypically similar staphylococci (2,
3). One such group of staphylococci is the Staphylococcus intermedius group (SIG),
which includes the species Staphylococcus delphini, Staphylococcus intermedius, and
Staphylococcus pseudintermedius (4). S. delphini has been further subdivided into two
distinct phylogenetic clades referred to as groups A and B (5). PYR test results were not
provided in the original description of S. delphini (6); however, a subsequent report
indicated that 100% of 22 S. delphini isolates (17 group A and 5 group B) were PYR
positive according to a commercial multibiochemical test strip (Rapid ID 32 Staph
[bioMérieux, Durham, NC, USA]) (5). As highlighted in Table 1, the PYR activity of S.
delphini is listed in some clinical reference texts as “not determined” or “not available,”
and in other references either S. delphini or the PYR test result is excluded from
Staphylococcus species identification tables (7–10). In comparison, the PYR activities of
S. intermedius and S. pseudintermedius are clearly documented as positive (7–9). Fur-
thermore, rather than using multibiochemical test strips, PYR activity is typically eval-
uated in the routine clinical microbiology setting with rapid PYR disc or slide kits, which
can be used in less than 5 min. Therefore, the purpose of this study was to determine
the PYR activities of S. delphini strains using the reference standard broth method (3)
to complete an important piece of “missing” biochemical data and to evaluate the
performance of four rapid PYR test kits produced by different manufacturers to assist
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clinical microbiologists in the rapid differentiation of S. aureus from the phenotypically
similar coagulase-positive SIG members.
RESULTS
Each PYR test kit reacted as expected with the control organisms (Streptococcus
agalactiae, negative; Enterococcus faecalis, positive). Only one manufacturer (Key Sci-
entific Products) included expected reactions for Staphylococcus species in its instruc-
tions. Nonetheless, the selected S. aureus (negative) and S. pseudintermedius (positive)
controls performed consistently with complete agreement for each test kit, at each test
point, and, in the case of the rapid PYR disc/slide tests, between laboratories. Positive
PYR reactions observed in the reference broth test were indicated with a brilliant
red-fuchsia color, while negative reactions were indicated by yellow or weakly orange
color (Fig. 1). Positive PYR reactions observed with the rapid disc and rapid slide tests
were of a similar red-pink color but were generally weaker than those observed with
the reference broth, and in these tests, Staphylococcus species (S. pseudintermedius and
S. delphini) produced weaker reactions than the control Enterococcus species. Results of
PYR tests for the 21 S. delphini and control strains are summarized in Table 2. Our results
show excellent agreement among the test systems (broth, rapid disc, and rapid slide),
TABLE 1 Documented PYR activities of S. aureus and members of the S. intermedius group represented in clinical reference texts
Clinical reference text
Documented PYR activitya
S. aureus S. delphini S. intermedius S. pseudintermedius
Manual of Clinical Microbiology, 11th ed (7) NEG Not determined POS POS
Koneman’s Color Atlas and Textbook of
Diagnostic Microbiology, 7th ed (8)
NEG Not available POS POS
Bailey and Scott’s Diagnostic Microbiology,
13th ed (9)
NEG Excluded POS POS
Clinical Veterinary Microbiology, 2nd ed (10) Excluded from identification table
aPYR, pyrrolidonyl arylamidase; NEG, negative; POS, positive.
FIG 1 Observed broth PYR reactions for the control and S. delphini DSM 20771T strains. 1, Enterococcus
faecalis ATCC 29212; 2, Streptococcus agalactiae ATCC 12386; 3, Staphylococcus aureus ATCC 25923; 4,
Staphylococcus pseudintermedius LMG 22219T; 5, Staphylococcus delphini DSM 20771T.
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manufacturers, and laboratories, with all S. delphini strains testing positive for PYR
activity except for one strain that tested negative with one rapid disc test kit in one
laboratory. Interlaboratory agreement, based on total number of rapid disc and rapid
slide tests (42 rapid disc/slide test results in total for both testing sites) performed on
all S. delphini strains was 97.6% (41/42 rapid disc/slide test results) (Table 2).
DISCUSSION
Of the tested S. delphini isolates in this study, 100% tested positive using the
reference PYR broth method, while 95% of the rapid disc/slide test results for the 21
S. delphini isolates were positive. The ability to accurately differentiate Staphylococcus
aureus from other phenotypically similar coagulase-positive staphylococci is important
for accurate interpretation of antimicrobial susceptibility test results that may influence
therapy selection. This has been demonstrated most clearly with respect to the detection
of methicillin susceptibility in S. aureus versus S. pseudintermedius (11). While some refer-
ence and larger hospital-based microbiology laboratories have turned to DNA sequencing-
or mass spectrometry-based technologies to rapidly and accurately identify Staphylococcus
species (12–14), many laboratories will continue to utilize single rapid tests and short test
sets for the identification of S. aureus and SIG members. The use of PYR testing to
distinguish some coagulase-positive Staphylococcus species from S. aureus is well estab-
lished (7, 8, 9; see also http://www.aavmc.org/data/files/case-study/burnham%20-%20staph
%20pseudintermedius%20-%20student%20materials.pdf). The rapid PYR disc methods
took 5 min to complete, while the reference broth method required 4 h. It should be
noted that strict adherence to manufacturer recommendations is required for all PYR-based
tests. It is especially important that PYR test reactions be read promptly after adding the
development reagent (N,N-dimethylaminocinnamaldehyde), since some negative reac-
tions may appear positive after increased time. Yellow-, salmon-, or orange-colored
reactions are generally considered by all manufacturers to be negative. It is recom-
mended that isolates exhibiting pale-pink or weak reactions be retested either with a
longer substrate incubation of 5 min, directly with reagent alone to determine if the
reactions are specific to the development reagent rather than the substrate, or using
the reference tube method.
The purpose of this study was to complete “missing” biochemical data for S. delphini
to facilitate the rapid differentiation of S. aureus and members of the SIG isolated from
animal and human clinical specimens. While S. pseudintermedius is increasingly recog-
nized as a potential human pathogen (11, 15), S. delphini and S. intermedius are
primarily animal pathogens. To the best of the authors’ knowledge, neither S. delphini
nor S. intermedius sensu stricto has been reported as a cause of human infection;
likewise, methicillin resistance has not been reported in these species. Each of the S.
delphini isolates used in this study was presumed to be susceptible to oxacillin by the
TABLE 2 Results of PYR broth and rapid PYR disc/slide testing at the two testing sites
Organisma
No. of strains
tested
Reference PYR brothb
(% of positive tests)
Rapid PYR disc/slide test results by
manufacturerc (% of positive tests)
A B C D
E. faecalis ATCC 29212 1 100 100 100 100 100
S. agalactiae ATCC 12386 1 0 0 0 0 0
S. aureus ATCC 25923 1 0 0 0 0 0
S. pseudintermedius LMG 22219T 1 100 100 100 100 100
S. delphini (group A) 9 100 100 100 100 94.4d
S. delphini (group B) 12 100 100 100 100 100
S. delphini (groups A and B) 21 100 100 100 100 97.6e
aLMG, Collection of the Laboratorium voor Microbiologie en Microbielle Genetica.
bThermo Fisher Scientific (Remel); tested only at the University of Tennessee.
cManufacturers are A, Thermo Fisher Scientific (Remel); B, Becton, Dickinson and Company; C, Hardy Diagnostics; and D, Key Scientific Products. All rapid test kits were
tested once in each of two laboratories.
dOne S. delphini group A isolate, S. delphini MI 09-2894, tested negative using the Key Scientific Products PYR disc kit at Weill Cornell Medical College. Of a total of 18
tests results available from both testing sites for the S. delphini group A isolates (9 results from each site), 94.4% (17/18) were positive.
eOf 42 test results from both testing sites available for the S. delphini group A and B isolates combined (21 results from each testing site), 97.6% (41/42) were positive.
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standard disk diffusion method (range of zone of inhibition diameters, 22 to 28 mm;
arithmetic mean, 26 mm) according to interpretive criteria used for S. pseudintermedius
(11), and the mecA gene was not detected by PCR (data not shown). Perhaps due to
misidentifications as S. aureus (12, 16) and the lack of routine species differentiation
within the SIG in some laboratories, the true epidemiology and distribution of S.
delphini infections in the human population may not be known. S. delphini has been
isolated from many different animal species (17–19), including some, such as horses,
that may have close human contact. Therefore, methods that can be used for quick
presumptive recognition of all members of the SIG (including S. delphini), such as PYR,
will be very useful in medical and veterinary clinical microbiology laboratories.
MATERIALS AND METHODS
Bacterial strains.We used four control strains: Enterococcus faecalis strain ATCC 29212, Streptococcus
agalactiae strain ATCC 12386, Staphylococcus aureus strain ATCC 25923 (American Type Culture Collec-
tion, Manassas, VA, USA), and Staphylococcus pseudintermedius strain LMG 22219T (received from Freddy
Haesebrouck, Ghent University, Ghent, Belgium). The Staphylococcus delphini strains used in this study
are summarized in Table 3. The S. delphini strain collection included seven previously published strains,
including the S. delphini type strain (S. delphini DSM 20771T) (received from Vincent Perreten, University
of Bern, Bern, Switzerland), and 14 clinical strains identified in this study. All isolates were cultured on
tryptic soy agar with 5% sheep blood (TSAB) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).
Initially, isolates (21 test strains and four control strains) were subcultured from long-term stocks and
incubated at 35  2°C in 5% carbon dioxide (CO2) for 18 to 24 h. Subsequently, these cultures were
subcultured and incubated at 35  2°C in 5% CO2 for 18 to 24 h prior to PYR testing.
Molecular identification of Staphylococcus delphini isolates. Bacterial cell lysates were obtained
from colonies grown on TSAB following incubation at 35 2°C in 5% CO2 for 18 to 24 h. A single isolated
colony was suspended in 0.5 ml of a 1:1 mix (vol/vol) containing Tris-EDTA buffer (10 mM Tris, 1 mM
EDTA [pH 8.0]) and 0.1-mm zirconium beads (Biospec Products, Bartlesville, OK, USA) and subsequently
vortexed to disrupt bacterial cells. The species and subgroup identification of S. delphini strains were
confirmed by thermonuclease (nuc) gene PCR using previously described primers (23). The total reaction
mixture for each PCR was 25 l, containing 2.5 l of supernatant from the bacterial cell lysate, 1 l of
each primer (final concentration, 10 pmol), 8 l of water, and 12.5 l of 2 PCR solution with a final
concentration of 0.625 U rTaq polymerase, 0.2 mM deoxynucleoside triphosphate mixture, and 1
reaction buffer (Premix Taq, TaKaRa Bio Inc., Kyoto, Japan). The thermocycler parameters were 1 cycle at
95°C for 1 min 30 s, 30 cycles at 56°C for 30 s, 72°C for 2 min 30 s and 94°C for 1 min, 1 cycle at 50°C
for 2 min, and 1 cycle at 72°C for 5 min, followed by holding at 4°C. Resultant PCR products were resolved
by agarose gel electrophoresis (1.0%) and visualized by staining with ethidium bromide (0.5 g/ml).
Antimicrobial susceptibility testing. Each S. delphini isolate was tested for oxacillin susceptibility
using the standard disk diffusion method as recommended by the Clinical and Laboratory Standards
Institute (CLSI) (24). Diameters of the zone of growth inhibition were recorded and, because no
interpretive breakpoints that apply specifically to this species exist, comparisons were made to the
TABLE 3 Staphylococcus delphini strains used in this study
Strain Group Host species Geographic origin Reference(s) or source
DSM 20771Ta A Dolphin Italy 6
VPP 12 D A Horse Switzerland This study
MI 09-8445 A Sea otter USA This study
MI 09-2894 A Raccoon USA This study
MI 16-1129 A Ferret USA This study
19-039 A Avian USA 11
52-006 A Horse USA This study
56-021 A Llama USA This study
62-031 A Horse USA This study
8086 B Horse UK 20
AV8047 B Pigeon Japan 20, 21
H4A B Horse Japan 5, 20
HT2003-0674 B Camel France 20, 22
P27B B Pigeon Japan 5, 20
P50 B Pigeon Japan 5, 20
26-037 B Horse USA 11
33-090 B Horse USA 11
35-016 B Horse USA 11
49-046 B Horse USA This study
53-033 B Horse USA This study
56-039 B Horse USA This study
aDSM 20771T, Deutsch Sammlung von Mikroorganismen und Zellkulturen GmbH, S. delphini type strain.
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current breakpoints used for S. pseudintermedius (11, 24). Bacterial cell lysates, obtained as described
above, were subjected to PCR for the mecA gene using previously described primers, thermocycling
conditions, and agarose gel electrophoresis method (25).
PYR testing. Four control strains were used to validate products each time S. delphini strains were
tested. Reference broth testing was performed using Remel PYR broth (catalog number 062085; Thermo
Fisher Scientific [Remel], Lenexa, KS, USA) at one location (University of Tennessee). Each isolate was
tested only once, and testing was performed and interpreted by a single individual according to
manufacturer instructions. PYR broth was inoculated with 4 colonies from an overnight TSAB plate
culture and incubated in an aerobic atmosphere for 4 h at 37°C. After incubation, 1 drop of PYR reagent
(catalog number R21258) was added to the tube. A red (positive) color reaction was recorded after
1 min and checked for significant change at 2 min. The following rapid disc or rapid slide tests were
tested: manufacturer A, PYR disc with reagent (catalog number R30854301; Thermo Fisher Scientific
[Remel]); manufacturer B, BBL DrySlide PYR kit (catalog number 231747; Becton, Dickinson and
Company); manufacturer C, PYR test kit and reagent (catalog number Z175; Hardy Diagnostics, Santa
Maria, CA, USA); and manufacturer D, PYR discs (with PEP) (catalog number K1538B; Key Scientific
Products, Stamford, TX, USA). For the rapid disc or rapid slide tests, testing was conducted independently
at two locations (University of Tennessee and Weill Cornell Medical College) using kits from identical lots.
At each site, isolates were assayed only once by each of the different disc or slide tests. Furthermore,
testing was performed and interpreted by a single individual at each site according to manufacturer
instructions. The sites were not blinded to the PYR activity of the control strains for the rapid PYR tests,
as this served as quality control prior to testing. However, all other testing factors were blinded. Discs and
slides were moistened with a 10-l loopful of distilled water, the incubation time of the organism on
discs and slides for all kits prior to addition of reagent was 2 min (including Key Scientific Products, which
indicates that the incubation time can be between 2 and 5 min), and the color reaction was recorded 1
min after addition of the reagent for all kits tested (including Key Scientific Products, which instructs at
least 1 min but not more than 2 min before recording).
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